Form 4 for STIM Neuronetics, Inc.
Accepted 2023-05-26 00:00:00 ET · period of report 2023-05-24 · accession 0001062993-23-012301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | 2023-05-24 | STIM | BAKEWELL JOHN K | Dir | S - Sale | $2.70 | -14.4K | 78.0K | -16% | -$38.9K | |
| 2023-05-26 | 2023-05-25 | STIM | BAKEWELL JOHN K | Dir | A - Grant | — | +36.4K | 114.4K | +47% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-24 | S | D | 14,400 | $2.70 | 77,988 | D | — | — | (F1) The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person to cover the reporting person's tax liability from a restricted stock unit ("RSU") award vesting on May 26, 2023. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.77. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-05-25 | A | A | 36,364 | — | 114,352 | D | — | — | (F3) Represents an RSU award that vests on the earlier of (a) May 23, 2024, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date. (F4) Each RSU represents a contingent right to receive one share of the Issuer's common stock. |